{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:46:57Z","timestamp":1793234817598,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008799","name":"Stiftung f\u00fcr Pathobiochemie und Molekulare Diagnostik","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008799","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.prostaglandins.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T04:04:38Z","timestamp":1464926678000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis"],"prefix":"10.1016","volume":"124","author":[{"given":"Sabrina","family":"Krautbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Eisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Wiest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bpg.2011.02.009","article-title":"Liver cirrhosis","volume":"25","author":"Pinzani","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0010","first-page":"2801","article-title":"Adiponectin, a key adipokine in obesity related liver diseases","volume":"17","author":"Buechler","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000323928","article-title":"Pathophysiology of non-alcoholic steatohepatitis and basis for treatment","volume":"29","author":"Pinzani","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0020","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF01537534","article-title":"Lipoproteins HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis","volume":"61","author":"Breier","year":"1983","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","article-title":"Albumin in chronic liver disease: structure, functions and therapeutic implications","volume":"10","author":"Spinella","year":"2015","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0035","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1021\/pr300683a","article-title":"Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry","volume":"11","author":"Zhou","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0040","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.3748\/wjg.v19.i22.3423","article-title":"Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma","volume":"19","author":"Liu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0045","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/ijms15022991","article-title":"Lipidomic analysis of serum from high fat diet induced obese mice","volume":"15","author":"Eisinger","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.25630","article-title":"Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis","volume":"56","author":"Tanaka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yexmp.2014.05.002","article-title":"Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes","volume":"97","author":"Eisinger","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.05.029","article-title":"Metabolism and atherogenic disease association of lysophosphatidylcholine","volume":"208","author":"Schmitz","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0070","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.1400699","article-title":"Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease","volume":"193","author":"Maricic","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0075","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1128\/AAC.04986-14","article-title":"Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii","volume":"59","author":"Smani","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0080","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.mehy.2015.10.013","article-title":"Fatty acyl composition of lysophosphatidylcholine is important in atherosclerosis","volume":"85","author":"Akerele","year":"2015","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0085","doi-asserted-by":"crossref","first-page":"34F","DOI":"10.1016\/j.amjcard.2008.04.017","article-title":"Lipoprotein-associated phospholipase A2 and risk of stroke","volume":"101","author":"Gorelick","year":"2008","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0090","first-page":"190","article-title":"Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat","volume":"105","author":"Sekas","year":"1985","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0005-2760(92)90261-S","article-title":"Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters","volume":"1128","author":"Subbaiah","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0100","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.yexmp.2015.01.010","article-title":"Reduced serum chemerin in patients with more severe liver cirrhosis","volume":"98","author":"Eisinger","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.regpep.2012.08.007","article-title":"Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury","volume":"179","author":"Bauer","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/eci.12122","article-title":"Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension","volume":"43","author":"Eisinger","year":"2013","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0130","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.3748\/wjg.14.7214","article-title":"Transjugular intrahepatic portosystemic shunt-placement increases arginine\/asymmetric dimethylarginine ratio in cirrhotic patients","volume":"14","author":"Siroen","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbalip.2004.09.003","article-title":"High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm","volume":"1686","author":"Liebisch","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0145","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1073\/pnas.94.6.2339","article-title":"Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry","volume":"94","author":"Brugger","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbalip.2005.12.007","article-title":"High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI\u2013MS\/MS)","volume":"1761","author":"Liebisch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0155","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/clinchem\/48.12.2217","article-title":"High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry","volume":"48","author":"Liebisch","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0160","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10620-006-9310-2","article-title":"Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status","volume":"51","author":"Wadhawan","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0165","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0170","doi-asserted-by":"crossref","first-page":"e111348","DOI":"10.1371\/journal.pone.0111348","article-title":"Alterations of plasma lysophosphatidylcholine species in obesity and weight loss","volume":"9","author":"Heimerl","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0175","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2174\/0929867322666150520095008","article-title":"Novel inflammatory markers in hyperlipidemia: clinical implications","volume":"22","author":"Papapanagiotou","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0180","first-page":"1","article-title":"Chemerin regulation and role in host defense","volume":"3","author":"Zabel","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.vph.2005.09.005","article-title":"Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells","volume":"44","author":"Jia","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0190","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2004.11.002","article-title":"MELD: the holy grail of organ allocation?","volume":"42","author":"Freeman","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0200","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","article-title":"Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis","volume":"64","author":"McPhail","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0205","first-page":"887","article-title":"Lysophosphatidylcholine and lysophosphatidylinosiol\u2013novel promissing signaling molecules and their possible therapeutic activity","volume":"71","author":"Drzazga","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0026-0495(93)90166-L","article-title":"Lecithin-cholesterol acyltransferase and lipid transfer protein activities in liver disease","volume":"42","author":"Tahara","year":"1993","journal-title":"Metab.: Clin. Exp."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.1840080113","article-title":"S-adenosyl-l-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis","volume":"8","author":"Duce","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.aca.2011.02.038","article-title":"Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry","volume":"691","author":"Cao","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00011-012-0434-x","article-title":"Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine","volume":"61","author":"Hung","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-511X-6-17","article-title":"Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status","volume":"6","author":"Taylor","year":"2007","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0235","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.biotechadv.2015.12.010","article-title":"Bioanalytical advances in assays for C-reactive protein","volume":"34","author":"Vashist","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0240","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.tem.2010.08.001","article-title":"Chemerin: at the crossroads of inflammation and obesity","volume":"21","author":"Ernst","year":"2010","journal-title":"Trends Endocrinol. Metab.: TEM"},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0245","first-page":"669","article-title":"Galectin-3 concentration in liver diseases","volume":"45","author":"Gudowska","year":"2015","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0250","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.3748\/wjg.v21.i32.9466","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis","volume":"21","author":"Lluch","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prostaglandins.2016.06.001_bib0255","first-page":"832","article-title":"Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration","volume":"299","author":"Nanji","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888231630034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109888231630034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T15:25:03Z","timestamp":1600701903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109888231630034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":51,"alternative-id":["S109888231630034X"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.06.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}